Souhaitez-vous accéder aux communiqués récents ?

Doha, Qatar, March 06, 2025 (GLOBE NEWSWIRE) -- Stobox, one of the leading global tokenization platforms, became a member of Qatar Financial Center Lab – the most prestigious and recognized Digital...

Rockville, MD, March 05, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, The automotive gesture recognition market was valued at USD 2,137 million in 2024 and has been forecast to expand at a...

AURORA, Colo., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sight Care, a new entrant in the vision-support space, proudly announces its revolutionary approach to maintaining and enhancing eye health without...

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)With as few as two treatments per year, Susvimo...

Regeneron shares corporate progress and highlights from the Company’s broad and diverse investigational pipeline.

Primary endpoint of DFS met at first prespecified interim analysis, showing a 68% reduction in the risk of disease recurrence or death in patients with high-risk CSCC after surgery compared to placebo...

Researchers have developed a highly efficient gene editing therapy that could potentially treat Stargardt disease, the most common form of inherited macular degeneration. This groundbreaking study,...

Vabysmo PFS is the first and only prefilled syringe containing a bispecific antibody, offering a convenient alternative to currently available Vabysmo vialsVabysmo has demonstrated rapid and robust...

Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "United States Retinal Surgery Devices Market Report Forecast by Product, Application, End-user, Countries and Company Analysis 2024-2032" report has...

·More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing...